All SGLT-2 inhibitors found promising for diabetes management in Indian settings: JAPI Medha Baranwal11 Jun 2022 11:30 AM ISTMaharashtra: SGLT2 Inhibitors could be considered as an add-on to all antidiabetic agents currently used for diabetes management in the Indian...
Glenmark gets CDSCO panel nod for Phase 4 study of anti-diabetic FDC drug Dr. Divya Colin21 March 2022 6:37 PM ISTNew Delhi: In line with the drug major Glenmark Pharmaceutical's revised Phase IV clinical trial protocol for anti-diabetic fixed dose combination...
Health Bulletin 18/November/2021 Roshni Dhar18 Nov 2021 5:43 PM ISTHere are Top Health stories of the daySupreme Court defers NEET PG Counselling 2021 hearing, Doctors launch Twitter storm demanding expeditionThe...
Glenmark gets CDSCO panel nod to market Remogliflozin, Teneligliptin, Metformin FDC drug Medical Dialogues Team17 Nov 2021 4:59 PM ISTNew Delhi: Granting permission for a local Phase III clinical trial and bioequivalence study waver, the Subject Expert Committee (SEC) of the Central...
Health Bulletin 28/October/2021 Roshni Dhar28 Oct 2021 10:52 AM ISTHere are Top Health Stories of the dayNMC to do away with positions of Tutor, Demonstrator, Registrar, bring them all under Senior Resident...
Glenmark launches Remogliflozin, Vildagliptin, Metformin FDC at Rs 16.50 per tablet Ruchika Sharma26 Oct 2021 1:35 PM ISTMumbai: Drugmaker, Glenmark Pharmaceuticals Limited, today announced that the company has launched a fixed dose combination (FDC) of its novel, patent...
Glenmark gets CDSCO panel marketing nod to Remogliflozin, Teneligliptin FDC Medical Dialogues Team18 July 2021 11:30 AM ISTNew Delhi: In a major rejoice to Mumbai-based Glenmark Pharmaceuticals Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard...
Health Minister discusses side-effects of SGLT-2 inhibitors in the parliament Meghna A Singhania8 Feb 2021 4:10 PM ISTNew Delhi: With the rising incidence of diabetes in the country, SGLT-2 inhibitors have emerged as one of the preferred modality of treatment....
NPPA brings Remoglifozin, Metformin combination under price control, pulls up Mankind, Intas Pharma for unapproved launch Farhat Nasim15 Jan 2021 7:06 PM ISTNew Delhi: In its recent most attempt to bring drugs under price control, NPPA has now set the maximum price for the FDC of Remoglifozin Etabonate and...
